TuttoCongressi
E-mail
Password
 Resta Collegato

Cerca per parole nell'archivio:
In archivio:
  • N° Relazioni: 478
  • N° Accessi Relaz.: 168934
Web Video
Portale Giovani Medici

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali Live Demo

   Mostra tutti | Mostra contenuti EasyRec   
10/09/2009
PIO-X
11:00 - 13:00
--PLENARY SESSION ? ADVANCES IN HIGH-RISK OBSTETRICS
Rizzo N. 
Twin pregnancy today
Tranquilli A. 
Intensive prenatal surveillance, when and where?
Valensise H. 
Intrauterine growth restriction, new concepts
Marozio L. 
Pathophysiology of pre-eclampsia: new insights
Todros T. 
New diagnostic tools to monitor high-risk pregnancy
14:00 - 16:00
--PLENARY SESSION ? ADVANCES IN OBSTETRICAL ENDOCRINOLOGY
Di Simone N. 
The role of resistin on throphoblast function
Pérez-López F. 
Vitamin D and pregnancy
Belaisch Allart J. 
The elderly pregnant woman
Ticconi C. 
Gestational diabetes: impact during and after pregnancy
16:20 - 16:50
--PLENARY LECTURE
Benagiano G. 
Evolution of the meaning of human sexuality
17:00 - 19:00
--ESTETROL: THE FETAL ESTROGEN - SPONSORED SYMPOSIUM ? ORGANIZED BY PANTARHEI BIOSCIENCE
Coelingh Bennink H. 
The properties of E4
Foidart J.M. 
The contraceptive use of E4
Skouby S. 
The non-contraceptive benefits of E4
 
PIO-X2
11:00 - 13:00
--ORAL PRESENTATIONS - ADVANCEMENTS IN ABORTION RESEARCH
Cocksedge K.A. 
How important is polycystic ovary syndrome as a cause of recurrent miscarriage?
Baek K-H. 
Identification of biomarkers in serum of recurrent pregnancy loss (RPL) patients
Calleja-Agius J. 
Inflammatory Cytokines in Early Pregnancy Loss
Finan R.R. 
Tumor Necrosis Factor-alpha Polymorphisms in Women with Idiopathic Recurrent Pregnancy Loss
Russu M. 
Pregnancy outcome after preconceptional vaginal micronized progesterone administration in recurrent pregnancy loss
Balajewicz M. 
Coincidental infections of Ureaplasma urealyticum and Mycoplasma hominis with Chlamydia trachomatis is significant factor in pathogenesis of threatened abortion and preterm delivery
Ege E. 
Knowledge and practices of emergency contraception of women who apply for induced abortion policlinic in Turkey
14:00 - 16:00
--ORAL PRESENTATIONS - THE BREAST
Jouybari L.M. 
How much women known about primary symptom of breast cancer?
Pfeiler G. 
Influence of the dramatic fall of HRT prescription on postmenopausal breast cancer incidence: the Austrian Data
Londero A. 
Anthropometric factors and reproductive history of a population of young women affected by benign breast disease
Ozdemir O. 
Nurses' Knowledge and Practice in Early Diagnosis of Breast and Cervix Cancer
Stolnicu S. 
Does low-grade intraductal acinic cell component explain a good prognosis in infiltrating primary acinic cell carcinoma of the breast?
17:00 - 19:00
--ORAL PRESENTATIONS - MODERN OBSTETRICS
Männistö T. 
Thyroid dysfunction and antibodies during pregnancy as a predictive factor for pregnancy complications and mothers' morbidity in later life
Uccella S. 
The association between fetal status during labor and first trimester papp-a levels
Procopciuc L.M. 
C677T and A1298C methylenetetrahydropholate reductase (MTHFR) polymorphisms in Romanian preeclamptic women. Influence in the perinatal outcome of preeclampsia
Pisaneschi S. 
Nitric oxide patway adaptive changes: a new perspective of research from fetal growth, to delivery, to peri-natal effects
Mahavarkar S.H. 
Our experience on cervical cerclage for cervical incompetence
Madhu C. 
A randomised controlled study comparing Drotaverine hydrochloride and Valethamate bromide in the augmentation of labour
Babbel B. 
Audit- Risk Factors and Cost Implications in Obese Women Undergoing Cesarean Section Compared to a Normal Weight Control Group
Dumitrascu I. 
Cavum septi pellucidi - where are the limits?
 
11/09/2009
PIO-X
08:30 - 09:00
PLENARY LECTURE
Schenker J. 
Pregnancy outcome following genetic maternal cryiopreservation
09:10 - 10:40
--SPRMS: TOWARDS A NEW PARADIGM IN THE TREATMENT OF UTERINE FIBROIDS - SPONSORED SYMPOSIUM - ORGANIZED BY PREGLEM SA
Fauser B. 
Why clinicians must re-evaluate what they can offer symptomatic patients
Bouchard P. 
SPRM class - Mode of Action and Do SPRMs differ from each other?
Mutter G. 
Features of selective progesterone receptor modulator (SPRM) associated endometrial changes
Nieman L. 
The proof of evidence: PGL4001 (ulipristal acetate) Phase II clinical data
Donnez J. 
SPRM in clinical practice ? Are there any implications for surgery?
11:00 - 13:00
--PLENARY SESSION ? STEROID RECEPTORS, NATURAL STEROIDS, SERMS AND SPRMS
Simoncini T. 
SERMs: osteoporosis and the breast
 

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali
Tuttocongressi ©1995 - 2026 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze  |  P.Iva 03755090481